Technical
Channels

Drug Discovery

Drug Development

Drug Manufacturing

Drug Delivery

Clinical Trials

Regulatory and Legal

Alliances and Mergers

QA/QC and Compliance

Pharmaceutical Processing and Packaging

Change text size [+] [-]

Zuellig Pharma Unveils Facility in Singapore

Friday, March 27, 2009
 Email This |  Printer Friendly

Zuellig Pharma has unveiled its upgraded Singapore facility, worth an estimated US$26 million. The 290,000 sq ft facility houses both the company's local distribution center and the Specialty Solutions Group.

The group is a regional consultancy and supply chain specialist, offering specialty pharma logistics services that range from supplying the clinical trial business in Asia to anti-counterfeit solutions. The group manages affiliates in India, China and Australia.


Share this:   Del.icio.us | 
Digital Edition



Singapore's Preclinical R&D industry should differentiate itself in Asia by competing on quality rather than on price.
Yes
No
View results


ABOUT PHARMA ASIA | FREE SUBSCRIPTION | CONTACT US

© 2010 Ten Alps Communications Asia. All rights reserved.
Use of this Web site is subjected to its Terms and Conditions of Use. View our Privacy Policy